Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been evaluated by three referees, whose reports are copied below. As you will see, while the referees find the identification of Ast1 as a new XPG-related nuclease potentially interesting and important, they at the same time raise a significant number of major issues and inconsistencies that would need to addressed before publication. Without repeating these points in detail here, I think it is fair to summarize the key concerns by saying that all referees would require conclusive further insight into the exact functional role of Ast1, particularly in DNA repair, in order to be able to support publication in The EMBO Journal. I realize that obtaining decisive further information of this kind may require a substantial amount of further time and effort and may also necessitate the employing of additional, complementary methodologies, and while I would in principle be happy to consider a revised manuscript addressing these issues further for publication, I would in this case also understand if you if you were to instead seek rapid publication without major changes elsewhere. Should you however be confident that you may be able to not only clarify the specific current concerns but also to further define the molecular role of Ast1 along the lines proposed by both the general (!) and the specific referee points, then I would encourage you to attempt these improvements and to submit a revised version for our further consideration. In this case I should remind you that it is our policy to allow only a single round of major revision and that it is therefore essential to comprehensively answer all points to the referees' satisfaction at this stage. Should you require any feedback or clarification regarding the reports or this decision, please therefore do not hesitate to get back to me.
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
When preparing your point-by-point response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
The manuscript reports the identification of a previously uncharacterised fission yeast nuclease the authors name Ast1. Ast1 was identified as a suppressor of an attenuated checkpoint response when over produced. The screen used is elegant. The data support a direct role in boosting the Chk1 signal ( Figure 1) .
The work is then progressed to attempt to show that Ast1 acts redundantly with two other related nucleases to promote Chk1 dependent cell cycle arrest. The two nucleases analysed, Rad2 (the fission yeast homolog of FEN1) and ExoI, are synthetically lethal when combined in the same cell. The manuscript exploits this observation to provide strong genetic evidence that Chk1 activation in this double mutant, which is presumed to be a response to incomplete Okazaki fragment maturation, is dependent on Ast1. These data are consistent with a role for the Ast1 nuclease in generating single stranded DNA (Figure 2A ) in this circumstance of cell growth in the absence of FEN1/Exo1. The observation is strongly supported by the further observation that the constitutive Chk1 phosphorylation present in both exo1 and FEN1 mutants is partially ast1 dependent Figure 1D ).
The authors predict from their data that Ast1 functions redundantly during DNA repair with FEN1 and Exo1 to promote single stranded DNA accumulation and thus Chk1 activation. The authors attempt to test this prediction using a variety of assays. To perform some of the necessary experiments the authors first generated an inducible strain where Exo1 can be depleted in the absence of FEN1 and Exo1 activities (Figure 3) The data generated in response to either UV damage or growth in the presence of MMS are not fully consistent with the authors conclusions. In each case, the interpretation would be more consistent with redundant functions for EXO1 and Rad2 in the DNA damage response, with no significant role for Ast1. However, to generate such a conclusion, it would be necessary to include exo1-so and FEN1 mutant cells for the assays presented in Figures 4 and 5. I suggest that this is done and the data re-assessed.
The authors demonstrate that Ast1 is recruited to the site of a single engineered DNA double strand break using chromatin immuno precipitation and that this is coherent with a decrease in a specific recombination assay that relies on extensive tracts of resection. Unfortunately, the authors are not able to expand this assay to demonstrate a direct effect on resection, which would validate this important conclusion.
In summary, I am of the opinion that this is a potentially important manuscript offering significant insight for the function of a relatively uncharacterised and conserved nuclease. The data clearly identify a role in checkpoint activation in unchallenged cells unable to complete replication due to a loss of FEN1 or Exo1. The weakness is the interpretation of the DNA repair data, which do not clearly support a general role in DNA processing in response to externally induced DNA lesions. This could be because the role is subtle and the experimental context required (loss of Exo1 and FEN1) obfuscates the readout of the required assays. Notwithstanding this, the work should be extended somewhat for these assays and interpreted appropriately before publication. A decisive demonstration of a DNA resection defect in the context of a targeted DNA double strand break would also greatly extend the interest of the work, irrespective of whether Ast1 is indeed involved in the processing event.
In the context of the introduction, the authors should introduce briefly their model system (page 3 middle of second paragraph) and take care to establish when the model is being discussed (the context of DNA damage and cChk1 activation) when compared to generic systems (Chk1 activation by ATR kinase homologs, the saturation of genetic screens) Referee #2 (Remarks to the Author):
In this new manuscript authors propose that three XPG nucleases, Ast1, Rad2 and Exo1 contribute to resection of 5' strands at damaged DNA in fission yeast. It is an interesting study and provides new insights into initial steps of DNA damage repair. Additional experiments/explanations are important to validate authors conclusions. Comments 1. It would be essential to demonstrate that overexpression of ast1 point mutant lacking nuclease activity does not suppress chk1-E472D sensitivity to MMS at 36C.
2. It is interesting that authors propose that Rad2 and Exo1 and Ast1 play redundant role in resection, yet only Ast1 was identified in the screen. Can rad2 or exo1 overexpression suppress MMS sensitivity of chk1-E472D mutant? 3. Fig. 4 . It is unclear why cells are grown for 2 hr at 25C instead immediately at 36C. Some fraction of cells grown at 25C in presence of thiamine may experience major replication problems before shifting to 36C. It would be important to demonstrate that cells incubated at 36C prior to UV radiation completed replication. Also it looks that conditional triple mutant enters G1 phase of the cell cycle faster than wild type without UV treatment, which is not expected. 4. Fig. 5A . It is surprising and contradictory that triple conditional mutant (ast1 rad2 exo1-so) shows better Chk1 activation after UV treatment than the double mutant (rad2 exo1-so) yet analysis on Fig.  4B implicates that double mutant has stronger checkpoint response after UV treatment. In general comparison of double and triple mutants is confusing because recovery from 36C w/o UV damage is so dramatically better in triple mutant when compared to double mutant.
5. And related to this: Fig. 7 . How to explain that exo1 rad2 double conditional mutant shows essentially no ssDNA formed after UV treatment while triple mutant exo1 rad2 ast1 has significant amount of ssDNA formed? Authors speculate on page 12 that Ast1 may inhibit MRX dependent but Exo1 and Rad2 independent resection. That is hard to believe because the picture on page 7 shows that long ssDNA (but lesser amount) is formed in exo1 rad2 ast1 while the work from other organisms both in vitro and in vivo, both in meiotic and mitotic cells suggests that MRX itself does not create long ssDNA at DNA damage sites. Therefore if authors conclusion/speculation is correct and Ast1 blocks activity of MRX one would expect to see more ssDNA but of shorter size. Also double mutants ast1 rad32 are more sensitive to DNA damage (MMS) than the single rad32 mutants that argues against the possibility that Ast1 is "an impediment to MRX complex" (page 12). 6. Fig. 6A . ChIP data are not particularly convincing with increases of 2 fold or even less in some cases (e.g. Rad52, 1kb left). 7. Fig. 6B . It would be good to provide examples of pictures in supplemental materials presenting differences in Rad52/RPA foci. It would be good to measure not only the fraction of cells with the focus but an average intensity of the focus. 8. Fig. 6C . Analysis in rad51 ast1 exo1 cells should be shown.
9. Authors use UV, MMS, bleomycin and HO nuclease experiments to validate importance of 3 nucleases in resection. It could possibly be beneficial if the focus was on single type of damage like UV or bleomycin and HO or MMS.
Minor Please indicate early in the manuscript that rad2 in fission yeast corresponds to major Okazaki fragment processing enzyme rad27 in budding yeast (as rad2 in budding yeast is rad13 in fission yeast).
Description of SSA on page 14. For any conclusion on SSA comparison of rad51 derivatives makes sense, not single mutants exo1, ast1 and rad51. The manuscript is well written and clearly identifies a role for a new member of the XPG family in checkpoint activation. Yet, when exposed to UV, deleting ast1 in a rad2 exo1-so strain appears to result in a modest increase in Chk1 activity, compared to rad2 exo1-so, which is curious, suggesting a more complex model for Ast1 in checkpoint activation.
Further, despite the authors commendable efforts, the experiments presented fail to clearly define the role for Ast1 in DNA repair. Thus the important question as to how Ast1 promotes checkpoint activation remains an open question. In this respect, this study would benefit from a more detailed analysis of Ast1 activity. This might include mutating the relevant XPG domains and examining the phenotypes and determining what substrates Ast1 preferentially binds and acts upon. From the genetic data, it seems likely that Ast1 may function independently of homologous recombination, and therefore further defining which pathway it acts in will be important in understanding its relationship to checkpoint activation.
Specific points:
It would be helpful to for the reader to be given the conditions in which the HO break was induced and when they did the ChIP analysis, perhaps in the figure legends rather than just referencing Outwin in the Materials and Methods.
Can the ast1 rad32 be suppressed by ku70 ? Which may help link Ast1 to a role in DSB repair and resection?
Fig2. The authors should show pictures of the cut nuclei to determine if cells exhibit the cut phenotype as opposed to just cell division.
Fig5B. ast1 should be ast1 Response to reviewers comments: Many thanks for the constructive reviews, which have aided us in improving the manuscript. Responses to specific concerns are below.
General response:
One general point in common to the reviews is the curious observation that the defects in Chk1 activation and ssDNA production are actually worse in the rad2∆ exo1-so double mutant than in the rad2∆ exo1-so ast1∆ triple mutant. Although this is not a dramatic effect, it has been consistent in all assays, and therefore cannot be ignored. The text has been modified and expanded in response to the individual comments below. To summarize, Ast1 (and Chk1) is clearly required for cell cycle delay in rad2∆ exo1∆ and rad2∆ exo1-so cells, thus Ast1 is necessary for a checkpoint response to endogenous damage in these double mutants, presumably generated during replication. Consistent with this, the spontaneous activation of Chk1 in rad2∆ and exo1∆ cells is also (largely) Ast1-dependent.
Combining these data with the behavior of the double and triple mutants suggests that although overexpressed Ast1 can amplify a checkpoint signal in G2, endogenous Ast1 functions in response to intrinsic damage caused by Rad2/Exo1 dysfunction, but perhaps not in response to extrinsic DNA damage incurred during G2 phase. However, we do note that Ast1 is recruited to DSBs in G2 cells, and that in rad2∆ exo1-so cells, both the extended time of recovery from a cdc25-22 arrest (presumably endogenous damage), and the further extended G2 cell cycle arrest caused by UV irradiation, are each Ast1-dependent (Fig 4) . Thus, we cannot completely rule out a role for Ast1 in responding to extrinsic DNA damage, albeit a minor one, and that Ast1 appears to be critical in the absence of MRN function.
Nevertheless, we still need to consider why the triple mutant is actually slightly better at Chk1 activation and end resection following irradiation, and have included additional data and discussion (see response to reviewers 2 and 3). We do not want to argue that these three XP-G-related nucleases are the end resecting enzymes, but do believe the data supports function for each of them in this event for endogenous and/or exogenous sources of DNA damage, at least as part of their repertoire of function.
Referee #1 (Remarks to the Author):
The work is then progressed to attempt to show that Ast1 acts redundantly with two other related nucleases to promote Chk1 dependent cell cycle arrest. The two nucleases analysed, Rad2 (the fission yeast homolog of FEN1) and ExoI, are synthetically lethal when combined in the same cell. The manuscript exploits this observation to provide strong genetic evidence that Chk1 activation in this double mutant, which is presumed to be a response to incomplete Okazaki fragment maturation, is dependent on Ast1. These data are consistent with a role for the Ast1 nuclease in generating single stranded DNA (Figure 2A ) in this circumstance of cell growth in the absence of FEN1/Exo1. The observation is strongly supported by the further observation that the constitutive Chk1 phosphorylation present in both exo1 and FEN1 mutants is partially ast1 dependent Figure  1D ).
Response: Regarding Figure 4 -This is an excellent point, and is the thrust behind much of the revised discussion.
We have added timecourse data for the single mutants to the supplementary data, and in keeping with published reports for rad2∆ and exo1∆, rad2∆ has a slightly longer delay than wild type (due to repair defects), and exo1-so behaves like wild-type cells. Thus, the extended delay of rad2∆ exo1-so cells is a synthetic phenotype presumably caused by spontaneous replicative damage that, importantly, is dependent on ast1. We have also noted these controls in the text. These points are further discussed below in the sections dealing with Chk1 activation and ssDNA production in the rad2∆ exo1-so and rad2∆ exo1-so ast1∆ strains.
Regarding Figure 5 -Western blot data showing Chk1 activation in rad2∆ and exo1∆ cells that is diminished in the absence of ast1 is presented in Figure 2D .
Response to two previous paragraphs: At the point we submitted the paper, the best system (in our hands) available for DSB formation in S. pombe was our tsHO, which only cuts ~20% of chromatids. This was used for these ChIP experiments, but was not efficient enough for end resection experiments. Hence, we used the formation of RPA and Rad51 foci (ssDNA binding proteins, Fig 6) and the formation of ssDNA following highdose UV irradiation (Fig 7A) to assay for ssDNA produced by resection.
However, a system with tet-regulated expression of I-PpoI, which cuts once in each rDNA repeat with an efficiency of ~90% was developed very recently by Kurt Runge and colleagues (Sunder et al (2012) Yeast 29:275) and we have used this and the ability of end resection to destroy restriction sites to assay for end resection by qPCR, and these new data are presented in Fig 7B. The data are consistent with the other assays, in that both rad2∆ exo1-so and rad2∆ exo1-so ast1∆ strains are defective in resecting this DSB, with again the double mutant being slightly worse than the double. Therefore we conclude a strong requirement for Rad2 and Exo1 in DSB resection.
In the context of the introduction, the authors should introduce briefly their model system (page 3 middle of second paragraph) and take care to establish when the model is being discussed (the context of DNA damage and cChk1 activation) when compared to generic systems (Chk1 activation by ATR kinase homologs, the saturation of genetic screens)
Response: This has been done.
Referee #2 (Remarks to the Author):
Response: Mutation of catalytic Aspartic Acids to Alanine ablates the suppressive activity of Ast1. This control has been added to figure 1.
2. It is interesting that authors propose that Rad2 and Exo1 and Ast1 play redundant role in resection, yet only Ast1 was identified in the screen. Can rad2 or exo1 overexpression suppress MMS sensitivity of chk1-E472D mutant?
Response: We were surprised not to isolate Rad2 and/or Exo1 given the number of times we isolated Ast1. We tested both these genes, and Rad2 weakly suppressed the MMS sensitivity of chk1-E472D. Rad2 does partially suppress the synthetic lethality of chk1-E472D cdc27-P11, but only at 32°C (32.5°C was used in the screen), and is weaker than the suppression conferred by Ast1, presumably too weak to survive the screen. These data are included in the supplementary material. Conversely, a genomic clone of Exo1 had no suppressive activity in either condition, behaving like vector only controls. It is possible that Rad2 and Exo1 are regulated in such as way that even overexpressed protein is controlled, but Ast1 is not.
3. Fig. 4 . It is unclear why cells are grown for 2 hr at 25C instead immediately at 36C. Some fraction of cells grown at 25C in presence of thiamine may experience major replication problems before shifting to 36C. It would be important to demonstrate that cells incubated at 36C prior to UV radiation completed replication. Also it looks that conditional triple mutant enters G1 phase of the cell cycle faster than wild type without UV treatment, which is not expected.
Response:
We used 4 hours at 36°C because we have previously reported (Harvey et al., (2004) MCB, 24: 662) that arresting cdc25-22 cells for longer than 4 hours at 36°C causes synthetic checkpoint defects, even to wild-type cells. We make note of this point in the text.
We have included FACS profiles in the supplementary data from these synchronizations, and other than the drift of signal to the right as cells elongate, no changes in DNA content suggestive of major replication problems are evident after two hours growth in thiamine are evident. At this timepoint Exo1 protein levels are down ~50% (Fig 3) , and although exo1∆ is not haplo-insufficient, we cannot rule out low-level replication associated lesions.
At the 30 and 45 minute timepoints, the triple mutant was consistently slightly faster at segregating chromosomes, though we note this includes a significant number of "cut" cells, which may slightly skew the data as these resolve slower. 4. Fig. 5A . It is surprising and contradictory that triple conditional mutant (ast1 rad2 exo1-so) shows better Chk1 activation after UV treatment than the double mutant (rad2 exo1-so) yet analysis on Fig. 4B implicates that double mutant has stronger checkpoint response after UV treatment. In general comparison of double and triple mutants is confusing because recovery from 36C w/o UV damage is so dramatically better in triple mutant when compared to double mutant.
No one was more surprised by these data than us, but they are highly reproducible, both in terms of replica experiments and with multiple independent isolates of these strains. Although we do see some Chk1 activation in the triple, it is reduced compared to wild-type cells and presumably has not passed the threshold sufficient to significantly delay the cell cycle. As stated above, we have included the single mutant controls to show this is a synthetic phenotype, and we cannot rule out that there are (and indeed assume there is) minor replication problems (not seen by FACS) in the double that cause the delay. Further, we have noted that basal Chk1 activity may be important in the double mutant, as a non-phosphorylatable chk1-S345A mutant does not behave as a null allele in this assay (though does in a wild-type cell).
5. And related to this: Fig. 7 . How to explain that exo1 rad2 double conditional mutant shows essentially no ssDNA formed after UV treatment while triple mutant exo1 rad2 ast1 has significant amount of ssDNA formed? Authors speculate on page 12 that Ast1 may inhibit MRX dependent but Exo1 and Rad2 independent resection. That is hard to believe because the picture on page 7 shows that long ssDNA (but lesser amount) is formed in exo1 rad2 ast1 while the work from other organisms both in vitro and in vivo, both in meiotic and mitotic cells suggests that MRX itself does not create long ssDNA at DNA damage sites. Therefore if authors conclusion/speculation is correct and Ast1 blocks activity of MRX one would expect to see more ssDNA but of shorter size. Also double mutants ast1 rad32 are more sensitive to DNA damage (MMS) than the single rad32 mutants that argues against the possibility that Ast1 is "an impediment to MRX complex" (page 12).
Response: Although the double produces little to no ssDNA, the increase in ssDNA production in the triple mutant is 1.25-fold (50J/m 2 ) and 1.44-fold (75J/m 2 ). For wild type, this is 3.53-and 3.28-fold, respectively. So, the triple is still significantly impaired. This assay matches our new I-PpoI data, where the double has very low level (but measurable) resection, and the triple shows significantly reduced resection compared to wild-type in the direction of transcription.
So how do we explain this? True enough, our argument regarding MRX impediment is not supported by the data and has been removed. At this point, therefore, we can only speculate as to why on one hand Ast1 overexpression amplifies signaling to Chk1, but it's deletion restores some degree of resection and Chk1 activation to the double. Ast1 is recruited to DSBs as, or even more efficiently than is Rad2 or Exo1 (as shown in Fig 6) . However, perhaps Ast1 is less effective (processive?) than other nucleases at resecting, and so when deleted (the triple mutant), Ast1 does not complete with these nucleases. Thus, there is more resection and more Chk1 activation in the triple than the double, but also more resection and more Chk1 activation when Ast1 is overexpressed by compensating for Ast1's inefficient processing (hence, the high-copy suppression). We have modified the discussion to remove the MRN argument in favor of alternative nucleases. 6. Fig. 6A . ChIP data are not particularly convincing with increases of 2 fold or even less in some cases (e.g. Rad52, 1kb left).
Response: Admittedly, Rad52 1kb left is low, but the signal 500bp right increases ~7-fold, and the three nucleases and RPA are also more convincing. It might be that Rad52 has not yet been recruited to the 1kb left locus. However, and more importantly, the efficiency of HO digestion in this system is only ~20%, and so all ChIP signals are a 5-fold underestimate of actual recruitment to total DSBs, rather than total chromatids. We had mentioned this in the text, but together with the comments of reviewer 3, this is further emphasized in both the methods and results sections. 7. Fig. 6B . It would be good to provide examples of pictures in supplemental materials presenting differences in Rad52/RPA foci. It would be good to measure not only the fraction of cells with the focus but an average intensity of the focus.
Response: I presume you mean Rad51/RPA foci? This has been added. We do not see large differences in intensity, though do not feel our protocols are sensitive enough to show subtle differences given the bleaching of GFP (on RPA) and the variables in processing cells for indirect immunofluorescence (for Rad51). However, one difference that is now noted in the text, is that wild-type cells show multiple Rad51 and RPA foci following UV irradiation, where we only saw single or occasionally two (perhaps coalesced) foci in both the rad2∆ exo1-so and rad2∆ exo1-so ast1∆ cells, though the significance of this is not clear as the relationship between focus number and DSBs is not 1:1. 8. Fig. 6C . Analysis in rad51 ast1 exo1 cells should be shown.
We neglected to say that we attempted this, but the triple mutant appears to be synthetic lethal. This is slightly complicated by the poor spore viability conferred by rad51∆, but we have failed to obtain a single triple mutant in over 150 tetrads, even considering microcolonies.
Response: In many cases, particularly in terms of checkpoint signaling, I would agree with you. However, in this case I thought it important to confirm that the observations were not specific to one type of DNA end, and so survival was performed in response to UV and MMS.
To induce rapid DNA damage in G2, we used UV, simply because of its rapidity and that we must irradiate quickly in these timecourse experiments as cells rapidly enter mitosis after removal from 36°C. Conversely, MMS requires passage through replication to inflict significant damage and thus cannot be used in these assays. Bleomycin was used only once to control for RPA foci in Fig 6, as these also form at sites of excision (which are also generated by UV and MMS). HO was only used in the ChIP assay, as at the time it was our only site-specific DSB.
Response: done.
Description of SSA on page 14. For any conclusion on SSA comparison of rad51 derivatives makes sense, not single mutants exo1, ast1 and rad51.
Response: Good point -changed. Figure 7 has only one part therefore description "A" on the figure is not needed.
Response: Our mistake -originally the loading control and quantification was B. However, B is now the resection assays from the I-PpoI site.
Referee #3 (Remarks to the Author):
The manuscript is well written and clearly identifies a role for a new member of the XPG family in checkpoint activation. Yet, when exposed to UV, deleting ast1 in a rad2∆ exo1-so strain appears to result in a modest increase in Chk1 activity, compared to rad2∆ exo1-so, which is curious, suggesting a more complex model for Ast1 in checkpoint activation.
Response: See general introductory comments and response to reviewer 2.
Response: Our data show that Ast1 is clearly required to mount a checkpoint response in cells lacking Rad2 and Exo1. Moreover, the data in Figure 6C clearly implicate Ast1 (and Exo1) in the Single-Stranded Annealing (SSA) pathway of homologous recombination. Moreover, the enhancement of MMS sensitivity of rad32∆ by ast1∆, a phenotype previously shown for rad32∆ and exo1∆, also implicate Ast1 in end processing (see also below for pku70∆ interactions).
The conservation of Ast1 from S. pombe to humans suggests an important function for this enzyme. The genetics of Ast1 function is complicated by the fact that ast1∆ cells have no obvious phenotypes by themselves, and thus the classic approach of epistasis analysis to define repair pathways is not applicable. We also note that ast1∆ cells do not display meiotic phenotypes, and so meiosis is not a source of the selective pressure for Ast1 conservation.
By analogy of the lack of strong phenotypes for exo1∆ and yet synthetic lethality with rad2∆, we have, however, looked for change of phenotype with the following mutants: mrc1∆, cds1∆, rqh1∆, srs2∆, mus81∆, slx1∆, rhp18∆, hsk1-ts, mcl1-ts, rad54∆, rhp57∆, ctf8∆, ctf18∆, swi10∆, rad16∆, nth1∆, mag1∆, pso2∆, and uve1∆ . In no case did we observe an increase in MMS or temperature sensitivity. This analysis is ongoing, with additional mutants and forms of DNA damage, and to extend to extend the analysis to triple mutants with either rad2∆ or exo1∆. Needless to say, this is an enormous amount of work, which is confounded by redundancy between and within pathways. It is also clear that many nucleases implicated in particular DNA repair pathways actually function in multiple pathways of repair and damage tolerance. To do justice to this analysis, both genetically and biochemically, is going to be at least a paper in itself, and I feel this is also likely to uncover functions for Ast1 that are independent from those described here.
Specific points:
Response: I have done this, plus the new I-PpoI methods as a separate section in the methods section.
Can the ast1∆ rad32∆ be suppressed by ku70∆? Which may help link Ast1 to a role in DSB repair and resection?
Response: I presume this question comes from the observation that pku70∆ can suppress rad32∆, but this is exo1-dependent? The interpretation of this observation is that in the absence of MRN, Ku70 is blocking access of Exo1 to DNA ends.
We have constructed these strains and made two interesting observations found in Fig 5. First, exo1∆ rad32∆ cells are very slow growing, and importantly this phenotype (but not the MMS sensitivity) is suppressed by pku70∆. Presumably the slow growth stems from endogenous DNA damage, and suggests that under these conditions Ku70 blocks a nuclease(s) other than Exo1.
Second, while ast1∆ enhances the MMS sensitivity of rad32∆, a remarkable phenotype given that ast1∆ by itself is not MMS sensitive, this is indeed suppressed by pku70∆. Therefore, Ast1 is also critical for MMS resistance in the absence of MRN, but not when ends of unprotected. Given the model and observations above, one presumes the suppression acts by granting access of DNA ends to Exo1. However, as ast1∆ exo1∆ cells remain MMS resistant, additional nucleases must function in this context, which is also consistent with the slow growth suppression of exo1∆ rad32∆ by pku70∆.
Response:
We have tried this, but unfortunately without success. These tetrads are dissected on plates containing the vital dye Phloxin B. On day 2 (24-36 hours post germination), the microcolonies are photographed. We score them as "cut" if they are dead (phloxin stained) dividing cells, or alternatively, cells with septa where one side is dead and the other side is viable (phloxin negative). Such dual stained cells reflect situations where the septum has displaced chromosomes unevenly, such that one daughter cell has enough DNA for viability, and consequently the other does not.
On day 4, the plates are replica-plated to genotype visible colonies, and the genotype of missing colonies is inferred from these data, and matched back to day 2 photos. However, by this stage (when we can find them) the non-wild-type genotypes shown in Fig 2 are now lysed cell ghosts. We have DAPI stained spores germinated from digested asci in liquid culture, and do see cuts in crosses to generate rad2∆ exo1∆ chk1∆ and rad2∆ exo1∆ ast1∆ strains, but cannot know the genotype of these spores.
I have taken new pictures of dissected tetrads with a color camera, which shows the distinction between phloxin-positive and negative cells better than the monochrome images provided in the original submission, but of course this is at lower resolution. I have also changed the text to reflect precisely what we are describing, and refer to later in the text where we have done DAPI staining after shutting off Exo1 expression, where we have quantified "cuts" (Fig 4) .
Fig5B. ast1 should be ast1∆
Response: Thank you -fixed.
While this is difficult to achieve using crosses, it is not clear to this referee why this cannot be performed by using the exo1-so shut off allele? Until a clear physiological 'cut' phenotype is associated with its loss in a rad2∆ exo1∆ background, then it is difficult to conclude a definitive role for Ast1 in promoting checkpoint activation, which is a central point. This is important because in figure 4, while deletion of ast1 in a rad2∆ exo1-so background reduces the time for cells to become post-mitotic, and thus could be associated with a checkpoint defect as claimed, this could also be due to increased DNA repair in G2 in this background, thus returning repair to wild-type levels and while the authors claim to have quantitated aberrant mitoses, until they have looked at DAPI stained nuclei, and shown these 'cutting' this is hard to interpret. In this respect, it would have been helpful to have shown the mitotic defects observed in these cells and indeed viability levels of these strains post cdc25-22 arrest and release and UV irradiation. It is possible that any loss of viability and thus presumably repair observed in figure 2C results from the replication roles of these XPG genes as opposed to DNA repair roles, as is of course discussed by the authors.
Indeed contrary to the proposed role for ast1 in promoting checkpoint activation, deleting ast1 in a rad2∆ exo1-so appears to increase the levels of phospho-Chk1-HA in response to UV towards wildtype, indicating that checkpoint activation clearly occurs in the absence of Ast1. Consistent with this, in Figure 7 there is increased ssDNA and resection in the ast1∆ rad2∆ exo1-so mutant compared to rad2∆ exo1-so, and resection levels in ast1∆ rad2∆ exo1-so are equivalent to wild-type (at least on the left hand side). Thus it would appear that Ast1 inhibits resection and in its absence this leads to increased resection and increased checkpoint activation in a rad2∆ exo1-so background, a very different conclusion from one in which Ast1 functions to promote checkpoint activation.
Helpful in-roads have been made regarding the role for Ast1 in DNA repair, yet these are still somewhat unclear. In this respect data is presented suggesting a role for ast1 in single-strand annealing. As indicated above, deletion of ast1 promotes resection at a DSB up to wild-type levels in an rad2∆ exo1-so background (Fig 7) , which while this may not necessarily be contradictory (ie ast1 may not required for the resection step during SSA), its role in repair is still unclear. However, data is also presented indicating that the ast1∆ delete exhibits increased sensitivity with rad32∆ and that this can be suppressed by deleting ku70∆. In this respect, it may be that the suppression of exo1∆ phenotype alone by ku70 deletion is enough to suppress this increased sensitivity exo1∆ with ast1∆. Therefore it could be that it is the failure to perform extensive resection at a break that promotes extra MMS sensitivity with exo1∆ ast1∆, and that this is suppressed by facilitating Exo1-independent extensive resection in the absence of Ku. This also fits with the reduced RPA foci andRad51 foci in Bleo treated rad2 exo1-so and ast1∆ rad2∆ exo1-so cells. It might be helpful to further confirm this by looking at either RPA foci and or resection levels in the exo1 ast1 double and exo1 ast1 ku70 triple mutants. Further, in this respect, it seems plausible that there might be a checkpoint defect (and cut-phenotype) associated with ast1∆ rad32∆, and that this may be a better route of enquiry as this may separate out the repair and replication issues associated with analysis using rad2.
In conclusion, while the manuscript is improved, the roles for Ast1 in checkpoint activation and DNA repair are unclear. Until a clearer role for ast1 in checkpoint activation and DNA repair has been defined, it is the opinion of this reviewer that the manuscript is still not yet ready for publication in the EMBO Journal Response to Referee #3.
This manuscript is not a study focusing solely on Ast1. It is true, as noted by this reviewer, that the suppression of Chk1 dysfunction by Ast1 overexpression is clear, and that interpreting the role of Ast1 in checkpoint function is less than clear. However, while Rad2/Fen1 and Exo1 have been studied for almost 20 years, we are still learning more about the function of these enzymes. Thus it would be unrealistic to fully understand the function of the third XPG-related nuclease in a single study.
Referee 3 asks to see a "cut" phenotype as evidence for checkpoint dysfunction. These data are provided in Fig 2A for rad2∆ exo1∆ ast1∆ cells, and in Fig 4C for strains using the exo1-so allele, albeit that this is not a complete null. These data have been in the paper since the initial submission. From these analyses, we have made the parsimonious conclusion that Ast1 (and Chk1) are required for the synthetic cell cycle arrest of cells lacking both Rad2 and Exo1. In keeping with this, ast1∆ diminishes spontaneous Chk1 activation in both rad2∆ and exo1∆ cells (Fig 2D) .
We have quantified the mitotic defects in the cdc25-22 synchronized cells (Fig 4C) , but we cannot measure viability as it takes 12-14 hours to reactivate Exo1 expression using the exo1-so allele, and the cells are long dead by this point. The survival data in Fig 2C are from irradiated asynchronous cultures, where only 10% cells are in S-phase, so it is unlikely that cell death in this particular experiment is significantly influenced by Okazaki fragment processing defects.
It is true that Fig 7 shows severe defects in ssDNA production in the absence of Rad2 and Exo1, and that ast1∆ actually restores this by a small though reproducible margin; this is not to wild-type levels considering the quantification of the southern blots, and the most robust resection of the IPpoI DSB in the direction of transcription. Despite this being a small effect, nobody was more surprised by this than us. Nevertheless, the phenotypes of the triple mutants show this is insufficient to induce a cell cycle arrest, and so the significance of what little ssDNA is made, and by whom, is unclear at this point. However, we thought it important to include these data.
Finally, regarding the role(s) for Ast1 in DNA repair, we think the best way forward is to determine a function for Ast1 in (otherwise) wild-type cells. The fact that Ast1 is conserved from S. pombe to humans argues that it must possess an important function, though like exo1∆ cells, ast1∆ cells by themselves are yet to display a phenotype. We are therefore working to investigate various scenario requiring nuclease activities that build on the initial analyses presented in this paper. These experiments require separation of S-phase from G2 functions, the use of defined lesions, and the consideration of genetic redundancy that extends beyond rad2 and exo1. As such, these studies are extensive. As with the many papers on Exo1 and Rad2/Fen1 function, deciphering Ast1 function is likely to contribute to a number of manuscripts, presumably from a number of laboratories. Therefore, we think it important to present our current findings to initiate study in this area.
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